Pliant Therapeutics IPO

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.

Register for Details

For more details on financing and valuation for Pliant Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Pliant Therapeutics's ticker symbol?

PLRX

What is Pliant Therapeutics's stock price?

27.15 as of 3/29/23

Learn more about Pliant Therapeutics

Forge green plus iconForge green minus icon

What is Pliant Therapeutics funding to date?

Pliant Therapeutics has raised $187MM.
Forge green plus iconForge green minus icon

When was Pliant Therapeutics founded?

Pliant Therapeutics was founded in 2016.